@article{5c093ae59b2a4c80b6d6ea451507dd35,
title = "Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter study",
keywords = "DOAC, PCC, prothrombin complex concentrate, reversal",
author = "Estroff, {Jordan M.} and Joseph Devlin and Lara Hoteit and Adnan Hassoune and Neal, {Matthew D.} and Brown, {Joshua B.} and Liling Lu and Shannon Kotch and Hazelton, {Joshua P.} and Christian, {Ashton B.} and Yeates, {Eric O.} and Jeffry Nahmias and Jacobson, {Lewis E.} and Jamie Williams and Schuster, {Kevin M.} and Rick O'Connor and Semon, {Gregory R.} and Straughn, {Angela D.} and Daniel Cullinane and Tanya Egodage and Michelle Kincaid and Allison Rollins and Richard Amdur and Babak Sarani",
note = "Publisher Copyright: {\textcopyright} Wolters Kluwer Health, Inc. All rights reserved.",
year = "2024",
month = oct,
day = "1",
doi = "10.1097/TA.0000000000004345",
language = "English",
volume = "97",
pages = "541--545",
journal = "Journal of Trauma and Acute Care Surgery",
issn = "2163-0755",
number = "4",
}